ESC Premium Access

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

Congress Session

About the speaker

Doctor Alexander Lynge Reese-Petersen

Nordic Bioscience, Copenhagen (Denmark)
0 follower

4 more presentations in this session

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

Speaker: Doctor G. Vergaro (Pisa, IT)

Thumbnail

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

Speaker: Doctor S. Kiddle (Cambridge, GB)

Thumbnail

Cysteine-rich angiogenic inducer 61 (CCN1) independently predicts all-cause mortality in patients with dilated cardiomyopathy

Speaker: Doctor R. Klingenberg (Bad Nauheim, DE)

Thumbnail

Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure

Speaker: Doctor G. Vergaro (Pisa, IT)

Thumbnail

Access the full session

Biomarkers to improve prognostication in heart failure: what's new?

Speakers: Doctor A. Reese-Petersen, Doctor G. Vergaro, Doctor S. Kiddle, Doctor R. Klingenberg, Doctor G. Vergaro
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

EHRA Premium Access

Closing words.

5 April 2022

ESC Premium Access

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

27 August 2021

ESC Premium Access

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

27 August 2021

This platform is supported by

logo Novo Nordisk